| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/06/2000 | EP0792149B1 Oral compositions containing ondansetron |
| 09/06/2000 | EP0719145B1 Nitric oxide donor composition for treatment of anal disorders |
| 09/06/2000 | EP0711146B1 Osmotic device having a vapor-permeable coating |
| 09/06/2000 | EP0711134B1 Medicinal for protection from neurological damage |
| 09/06/2000 | EP0587858B1 Protein formulation comprising growth hormone |
| 09/06/2000 | CN2394606Y Seractide containing bandage |
| 09/06/2000 | CN1265595A Pharmaceutical composition containing vitamin D and calcium, their preparation and therapeutic use |
| 09/06/2000 | CN1265593A Novel process for manufacturing paroxetine solid dispersions |
| 09/06/2000 | CN1265587A Fast-acting analgesic |
| 09/06/2000 | CN1265584A Ascorbic acid-based formulation with improved colour stability |
| 09/06/2000 | CN1265583A Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
| 09/06/2000 | CN1265560A Composition and method for curing diabetes |
| 09/06/2000 | CN1265327A Making process of subunit antigen vaccine cream |
| 09/06/2000 | CN1265324A Thrombus-eliminating blood circulation promoting injecta |
| 09/06/2000 | CN1265323A Pain-stopping fracture healing plaster and its preparation |
| 09/06/2000 | CN1265321A Resina Draconis preparation as one Chinese medicine and its preparation process |
| 09/06/2000 | CN1265318A Xiancaoteng capsule made of korean epimedium herb, liquorice root and common threewingnut root and its preparation |
| 09/06/2000 | CN1056154C Method of producing reconstituted lipoproteins |
| 09/06/2000 | CN1056083C Method and compositions for treatment and repair of defects or lesions in cartilage |
| 09/06/2000 | CN1056079C External application plaster for preventing and curing bronchial asthma and bronchitis |
| 09/06/2000 | CN1056076C Prepn. of injection with Radix Sophorae flavescentis and Radix pulsatillae |
| 09/06/2000 | CN1056075C Chinese medicine ointment |
| 09/06/2000 | CN1056071C Hepatitis virus inhibitor and prepn. method thereof |
| 09/06/2000 | CN1056070C Preparation for isatis root syrup |
| 09/06/2000 | CN1056059C Prescription for curing gonorrhea and its preparing process |
| 09/06/2000 | CN1056058C Prep. of pharmaceutical formulation |
| 09/06/2000 | CN1056057C Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administraion |
| 09/06/2000 | CN1056056C Enteric solubility bacterial enzyme composite bed microcapsule preparation and its preparing method |
| 09/05/2000 | US6114398 Personal lubricant to prevent and stop itching |
| 09/05/2000 | US6114348 Method of treating warts using tazarotene |
| 09/05/2000 | US6114324 Mirtazpine in water solution or suspension |
| 09/05/2000 | US6114319 Compositions containing difluprednate |
| 09/05/2000 | US6114313 Mixture of nucleotide, mannitol and adjuvants |
| 09/05/2000 | US6113948 Microparticles and their use in wound therapy |
| 09/05/2000 | US6113947 Controlled release microencapsulated NGF formulation |
| 09/05/2000 | US6113946 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 09/05/2000 | US6113945 Cores with covering envelopes and colors |
| 09/05/2000 | US6113944 Mixing with excipients and compression into tablets |
| 09/05/2000 | US6113943 Active substance with hydrolyzed lactic acid polymer |
| 09/05/2000 | US6113942 Pharmaceutical composition for piperidinoalkanol compounds |
| 09/05/2000 | US6113941 Substained release microcapsule of physiologically active compound which is slightly water soluble at pH 6 to 8 |
| 09/05/2000 | US6113940 Drug delivery with transdermal patch layer which carries the cannabis chemical(s). the chemicals are contained in a film on the |
| 09/05/2000 | US6113939 Pharmaceutical compositions for treating priapism and peyronie's syndrome |
| 09/05/2000 | US6113938 Beneficial agent delivery system with membrane plug and method for controlling delivery of beneficial agents |
| 09/05/2000 | US6113937 Sustained release sufentanil compositions |
| 09/05/2000 | US6113936 Method for microencapsulating a solid substance |
| 09/05/2000 | US6113935 Water in oil microcapsules with water in shells of urea-formaldehyde polymers or melamine formaldehyde polymers |
| 09/05/2000 | US6113932 Nontoxic vernix compositions and method of producing |
| 09/05/2000 | US6113919 Preparations comprising a fluorocarbon or a highly fluorinated compound and a lipophilic/fluorophilic compound and their uses |
| 09/05/2000 | US6113894 Treatment of blepharitis of the cornea of eyes, applying compositiion with viscosity adjusting agent, preservatives, buffers, nonionic surfactants and lipids |
| 09/05/2000 | US6113893 Solvent, alcohol, alkali with vinyl acetate-crotonic acid copolymer or polyvinyl acetate phthalate and plasticizers |
| 09/05/2000 | CA2299952A1 Improved pellet formulations |
| 09/05/2000 | CA2279608C Container for moisture-sensitive material |
| 09/05/2000 | CA2202520C Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation |
| 09/05/2000 | CA2083683C Stable formulation of analapril salt, a process for the preparation thereof and the use thereof |
| 09/05/2000 | CA2058428C Analgesic formulations |
| 09/05/2000 | CA2009090C Process for producing solid pharmaceutical preparations |
| 08/31/2000 | WO2000050617A1 Intravascular delivery of non-viral nucleic acid |
| 08/31/2000 | WO2000050386A1 Compounds and compositions for delivering active agents |
| 08/31/2000 | WO2000050349A2 Biodegradable ceramic fibres from silica sols |
| 08/31/2000 | WO2000050084A1 Stable formulation containing fumagillin |
| 08/31/2000 | WO2000050083A1 Enteral sorbefacients |
| 08/31/2000 | WO2000050078A1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens |
| 08/31/2000 | WO2000050062A2 Methods and compositions for altering mucus secretion |
| 08/31/2000 | WO2000050050A1 Multiparticulate formulation |
| 08/31/2000 | WO2000050047A2 Composition for the treatment of psoriasis |
| 08/31/2000 | WO2000050046A1 Stabilized oral pharmaceutical composition containing iodide and iodate and method |
| 08/31/2000 | WO2000050041A1 Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose |
| 08/31/2000 | WO2000050038A1 Pharmaceutical composition containing proton pump inhibitors |
| 08/31/2000 | WO2000050036A1 Storage stable amoxycillin and clavulanate suspension composition |
| 08/31/2000 | WO2000050035A2 Premixed formulation of piperacillin sodium and tazobactam sodium injection |
| 08/31/2000 | WO2000050029A1 Seam soft capsule preparations containing dihydrobenzofuran derivative |
| 08/31/2000 | WO2000050018A2 Pharmaceutical preparation containing dithranol |
| 08/31/2000 | WO2000050016A2 Compositions and methods for improving integrity of compromised body passageways and cavities |
| 08/31/2000 | WO2000050015A1 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine |
| 08/31/2000 | WO2000050014A2 Phenytoin sodium pharmaceutical compositions |
| 08/31/2000 | WO2000050013A1 Rapidly-soluble compositions |
| 08/31/2000 | WO2000050012A1 Solid oral dosage form containing an enhancer |
| 08/31/2000 | WO2000050011A1 Controlled release formulation for treating copd |
| 08/31/2000 | WO2000050010A1 Controlled release bupropion formulation |
| 08/31/2000 | WO2000050009A1 Methods for administering pharmacologically active compounds to vertebrates |
| 08/31/2000 | WO2000050008A2 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 08/31/2000 | WO2000050007A1 Compositions and methods for improved delivery of hydrophobic therapeutic agents |
| 08/31/2000 | WO2000050006A2 Microemulsions with adsorbed macromoelecules and microparticles |
| 08/31/2000 | WO2000050005A1 Liquid suppository composition of diclofenac sodium |
| 08/31/2000 | WO2000050004A2 Surgical anesthesia delivery system |
| 08/31/2000 | WO2000049991A2 Treatment of trauma |
| 08/31/2000 | WO2000049990A2 The process for manufacturing topical ophthalmic preparations without systemic effects |
| 08/31/2000 | WO2000036113A3 Extending graft survival by heme oxygenase-i expression induced immunomodulation |
| 08/31/2000 | WO2000030611A3 Pharmaceutical preparation |
| 08/31/2000 | WO2000027849A3 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 08/31/2000 | WO2000025753A3 Controlled delivery of active agents |
| 08/31/2000 | WO2000023055A9 Oral pulsed dose drug delivery system |
| 08/31/2000 | WO2000021594A3 Flow resistance modulated aerosolized active agent delivery |
| 08/31/2000 | WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 08/31/2000 | WO1999042086A9 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 08/31/2000 | DE19957472A1 Verfahren zur Herstellung von Arzneimitteln in fester Darreichungsform aus pflanzlichen Extrakten A process for the preparation of medicaments in a solid dosage form from plant extracts |
| 08/31/2000 | DE19908537A1 Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas Use of 2-amino-thiazole polycyclic systems for the production of medicaments for the prophylaxis or treatment of obesity |
| 08/31/2000 | DE19908487A1 Pharmazeutische Zubereitung enthaltend Dithranol Pharmaceutical composition containing dithranol |
| 08/31/2000 | DE19908210A1 Aerosol compositions, which are stable and are free of hydrofluorocarbons, include a medicament, a sorbitan trifatty acid ester surfactant and propane as propellant |